Myriad Genetics buy Raymond James
Start price
25.02.25
/
50%
€11.40
Target price
25.02.26
€18.10
Performance (%)
-65.44%
End price
26.02.26
€3.94
Summary
This prediction ended on 26.02.26 with a price of €3.94. The BUY prediction by Raymond_James for Myriad Genetics performed very badly with a performance of -65.44%. Raymond_James has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | 13.402% | 13.402% | -53.927% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $19.00 price target on the stock, down previously from $27.00.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten